<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>endocrinology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>endocrinology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease
Authors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.
Score: 3.1, Published: 2023-07-12 DOI: 10.1101/2023.07.10.23292471
AimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/endocrinology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="endocrinology" />
<meta property="og:description" content="Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease
Authors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.
Score: 3.1, Published: 2023-07-12 DOI: 10.1101/2023.07.10.23292471
AimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/endocrinology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-07-23T10:36:34+00:00" />
<meta property="article:modified_time" content="2023-07-23T10:36:34+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="endocrinology"/>
<meta name="twitter:description" content="Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease
Authors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.
Score: 3.1, Published: 2023-07-12 DOI: 10.1101/2023.07.10.23292471
AimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "endocrinology",
      "item": "https://trxiv.yorks0n.com/posts/endocrinology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "endocrinology",
  "name": "endocrinology",
  "description": "Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease\nAuthors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.\nScore: 3.1, Published: 2023-07-12 DOI: 10.1101/2023.07.10.23292471\nAimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort.",
  "keywords": [
    
  ],
  "articleBody": " Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease\nAuthors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.\nScore: 3.1, Published: 2023-07-12 DOI: 10.1101/2023.07.10.23292471\nAimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort. We tested the association for potential causality between genetically determined Lp(a) concentrations and disease outcomes using a Mendelian randomization (MR) strategy. MethodsUsing an extended biomarker dataset, we identified 47,840 participants with very low Lp(a) concentrations (\u003c3.8 nmol/L) from a total of 449,026 participants. With a median follow-up of 12.4 years (interquartile range 11.5-13.1), we assessed the risk of new-onset cardiometabolic diseases in these participants stratified by usage of lipid-lowering medication using Cox proportional hazards models. We performed two sample MR analyses to test causal relationship between genetically predicted Lp(a) and T2D and NAFLD. ResultsCompared to participants with Lp(a) within the standard reportable range of 3.8-189 nmol/L, participants with very low Lp(a) (\u003c3.8 nmol/L) were at increased risk of developing both T2D (HR 1.07; 95% CI 1.01-1.12) and NAFLD (HR 1.36; 95% CI 1.26-1.46) as opposed to decreased risk for coronary artery disease. The risk for new-onset T2D was higher in participants using lipid-lowering medication (fully adjusted HR 1.16; 95% CI 1.06-1.26). On the other hand, there was higher risk of NAFLD in participants not on lipid-lowering medication (HR 1.39; 95%CI 1.27-1.51). There was no evidence for causal links between genetically predicted Lp(a) and T2D or NAFLD in two sample MR analyses. ConclusionsVery low Lp(a) was associated with higher risks of T2D and NAFLD in a prospective analysis of the UK Biobank. These associations were influenced by lipid lowering medication usage. MR analyses did not support causality for these inverse associations.\n",
  "wordCount" : "323",
  "inLanguage": "en",
  "datePublished": "2023-07-23T10:36:34Z",
  "dateModified": "2023-07-23T10:36:34Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/endocrinology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      endocrinology
    </h1>
    <div class="post-meta"><span>updated on July 23, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.07.10.23292471">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.07.10.23292471" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.07.10.23292471">
        <p class="paperTitle">Very Low Lipoprotein(a) Levels Are Associated With Higher Risks Of New-Onset Diabetes And Non-Alcoholic Liver Disease</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.07.10.23292471" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.07.10.23292471" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Yeung, M. W.; Said, M. A.; van de Vegte, Y. J.; Verweij, N.; Dullaart, R. P.; van der Harst, P.</p>
        <p class="info">Score: 3.1, Published: 2023-07-12 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.07.10.23292471' target='https://doi.org/10.1101/2023.07.10.23292471'> 10.1101/2023.07.10.23292471</a></p>
        <p class="abstract">AimWe aimed to study the association of very low serum Lipoprotein(a) [Lp(a)] concentrations with new-onset type 2 diabetes (T2D) and non-alcoholic liver disease (NAFLD) in the context of lipid-lowering medication usage in the UK Biobank, a large prospective population cohort. We tested the association for potential causality between genetically determined Lp(a) concentrations and disease outcomes using a Mendelian randomization (MR) strategy.

MethodsUsing an extended biomarker dataset, we identified 47,840 participants with very low Lp(a) concentrations (&lt;3.8 nmol/L) from a total of 449,026 participants. With a median follow-up of 12.4 years (interquartile range 11.5-13.1), we assessed the risk of new-onset cardiometabolic diseases in these participants stratified by usage of lipid-lowering medication using Cox proportional hazards models. We performed two sample MR analyses to test causal relationship between genetically predicted Lp(a) and T2D and NAFLD.

ResultsCompared to participants with Lp(a) within the standard reportable range of 3.8-189 nmol/L, participants with very low Lp(a) (&lt;3.8 nmol/L) were at increased risk of developing both T2D (HR 1.07; 95% CI 1.01-1.12) and NAFLD (HR 1.36; 95% CI 1.26-1.46) as opposed to decreased risk for coronary artery disease. The risk for new-onset T2D was higher in participants using lipid-lowering medication (fully adjusted HR 1.16; 95% CI 1.06-1.26). On the other hand, there was higher risk of NAFLD in participants not on lipid-lowering medication (HR 1.39; 95%CI 1.27-1.51).

There was no evidence for causal links between genetically predicted Lp(a) and T2D or NAFLD in two sample MR analyses.

ConclusionsVery low Lp(a) was associated with higher risks of T2D and NAFLD in a prospective analysis of the UK Biobank. These associations were influenced by lipid lowering medication usage. MR analyses did not support causality for these inverse associations.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
